Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis - Archive ouverte HAL Access content directly
Journal Articles European Journal of Medicinal Chemistry Year : 2020

Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis

(1, 2) , (3) , (2) , (1) , (3) , (3) , (4) , (5) , (3, 4) , (1) , (1)
1
2
3
4
5

Abstract

Several phenanthrolinic analogs of quinolones have been synthesized and their antibacterial activity tested against Mycobacterium tuberculosis, other mycobacterial species and bacteria from other genera. Some of them show high activity (of the range observed for rifampicin) against M. tuberculosis replicating in vitro and in vivo (infected macrophages) conditions. These derivatives show the same activity with all or several M. tuberculosis complex bacterial mutants resistant to fluoroquinolones (FQ). This opens the way to the construction of new drugs for the treatment of FQ resistant bacterial infections, including tuberculosis. Several compounds showed also activity against Staphylococcus aureus and probably other species. These compounds do not show major toxicity. We conclude that the novel phenanthrolinic derivatives described here are potent hits for further developments of new antibiotics against bacterial infectious diseases including tuberculosis in particular those resistant to FQ.
Fichier principal
Vignette du fichier
S0223523420307935.pdf (717.22 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-03261309 , version 1 (21-09-2022)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

Cite

Songuigama Coulibaly, Mena Cimino, Mahama Ouattara, Cédric Lecoutey, Maria V Buchieri, et al.. Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis. European Journal of Medicinal Chemistry, 2020, 207, pp.112821. ⟨10.1016/j.ejmech.2020.112821⟩. ⟨pasteur-03261309⟩
18 View
52 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More